Happy Friday!
Busy finish to a short month here at Peak
Market Highlights
ASX 200 futures are pointing down 11 points or 0.1 per cent to 9151.
All US prices near 3.15pm New York time.
- AUD -0.2% to US71.09¢
- Bitcoin -1.5% to $US67,722
- On Wall St: Dow -0.4% S&P -1.1% Nasdaq -1.9%
- VIX +0.80 to 18.73
- Gold +0.5% to $US5192.38 an ounce
- Brent oil -0.03% to $US70.83 a barrel
- Iron ore +0.1% to $US98.30 a tonne
- 10-year yield: US 4.01% Australia 4.70%
Across Markets…
Australian shares are set to open modestly lower, dragged down by a wave of selling in New York after Nvidia’s blockbuster quarterly results failed to offset concerns AI is poised for further disruption.
Oil gave up all its earlier gains after the US and Iran agreed to extend their talks into next week after a third round of negotiations in Geneva on Thursday (Friday AEDT).
ASX 200 futures were down 11 points or 0.1 per cent to 9151 near 7.15am AEDT. The S&P 500 were 0.6 per cent lower at 3.17pm in New York, halving earlier losses.
Nvidia slumped 5.6 per cent. Broadcom shed 4.5 per cent. The Philadelphia semiconductor index lost 3.8 per cent. Barring a massive late day turnaround, this will be the seventh straight quarter where Nvidia shares fell from the open to the close of trading on the day after it reports earnings.
“The fact that Nvidia just posted $US68.1 billion ($95.8 billion) in quarterly revenue, yet markets are unimpressed, is telling,” said to Adam Kobeissi, who publishes The Kobeissi Letter. “Nvidia’s free cash flow jumped nearly $US20 billion year-over-year and the company crushed just about all expectations.”
“Because expectations are so high that it’s becoming difficult to impress, Kobeissi said in a post on X. “At this stage, companies do not just need to beat earnings, they need to beat the beat.”
In its first six earnings reports following the release of ChatGPT, Nvidia shares averaged a one-day gain of more than 10 per cent on its earnings reaction day, according to Bespoke Investment. Following its last seven reports, though, shares have averaged a decline of 3 per cent.
In contrast to the collapse in chip stocks, software shares rebounded. Atlassian was 8.4 per cent higher, helping to almost reverse its losses over the past five days.
Source: AFR
Nova is aiming to build one of the ASX’s biggest gold projects AND win America’s antimony race
- Nova Minerals owns one of the ASX’s largest gold assets – the 9.9Moz Estella project in Alaska
- It also has a US$43m US Government grant to become a military-grade antimony producer as soon as this year
- PFS due in mid-2026 as $400m gold player eyes rerate potential
For a long time a sleeper on the ASX, 2025 proved a breakout year for Alaskan gold and antimony developer Nova Minerals (ASX:NVA).
The $400 million capped firm saw its shares hit a three-year high of $1.54 in October last year, powered by a wave of enthusiasm around critical minerals stocks as Donald Trump’s America and Anthony Albanese’s Australia knocked up a deal to invest in metals dominated by China.
But back at 86c today, the investment proposition is arguably even stronger for Nova, with a US$43 million grant in hand from the US Department of Defense to fast-track antimony production at the same time as gold prices eclipse US$5000/oz.
That’s put real ballast behind its already large Estelle gold project in the 220Moz Tintina gold belt, one of the most substantial across any ASX junior in terms of ounces in the ground at 9.9Moz.
By way of comparison, Canadian market darlings Snowline Gold (~8Moz at 1.21g/t) and New Found Gold (2Moz at a higher grade ~2g/t) are running at respective valuations of C$3.1bn and C$1.2bn, while on the American mainland Montana antimony smelter operator US Antimony is trading at a US$1.2bn market cap.
“I mean you know there’s obviously differences between all these companies but those are some good comparables to look at when the re-rates come,” Nova executive director and CEO Christopher Gerteisen said.
While the best laid schemes of mice and men often go awry, Nova has a string of in-built catalysts Gerteisen thinks can get the firm to its goal – eventually becoming a major gold producer at the same time as it develops one of a handful of domestic antimony assets ready to supply the US military.
Antimony: The immediate upside
There are two big catalysts on the horizon, according to Gerteisen. One is a pre-feasibility level study for Estelle’s RPM and Korbel gold deposits.
It will build on a 2023 scoping study that projected a mine churning out 2.25Moz over more than 17 years that boasted a 53% internal rate of return at a gold price of just US$1800 per ounce.
With spot gold recently hitting as much as triple that, the upside is obvious even before pen hits paper.
Then there is the short-term upside in developing one of a handful of US antimony deposits that could be producing as soon as this year.
The aforementioned Department of Defense/War grant will allow Nova to dig out massive stibnite veins literally popping out of the ground like Arnold’s biceps in Pumping Iron. Nova will process them 100km away at a facility in Port Mackenzie.
Nova’s aim is to supply clean, high-grade antimony tri-sulphide to the Pentagon, the product used in munitions.
To read more, click here
Company: Fin Resources Ltd (ASX:FIN)
Sector: Gold/Mining
Deal Type: Placement
Latest Entry Price: $0.0065
Performance Since Entry: +100%
Company: Eden Innovations (ASX:EDE)
Sector: Construction/Clean Energy
Deal Type: Shortfall
Latest Entry Price: $0.035 with 1:2 option, strike $0.07
Price Performance Since Entry: +357%
Company: Tasman Resources Ltd (ASX:TAS)
Sector: Gold/Silver/Mining
Deal Type: Placement
Latest Entry Price: $0.0125 with 1:2 option, strike $0.02
Price Performance Since Entry: +396%
Company: Locksley Resources Ltd (ASX:LKY)
Sector: REE & Antimony/Mining
Deal Type: Placement
Latest Entry Price: $0.04
Price Performance Since Entry: +325%
Company: CuFe Ltd (ASX:CUF)
Sector: Copper/Mining
Deal Type: Placement
Latest Entry Price: $0.016 with 1:2 option, strike $0.025
Price Performance Since Entry: +188%
Company: Tambourah Metals Ltd (ASX:TMB)
Sector: Gold/Mining
Deal Type: Placement
Latest Entry Price: $0.04
Price Performance Since Entry: +50%
Company: Biotron Ltd (ASX:BIT)
Sector: Biotech
Deal Type: Placement
Latest Entry Price: $0.003 with 1:2 option, strike $0.02
Price Performance Since Entry: 0%
Company: Eclipse Metals Ltd (ASX:EPM)
Sector: REE
Deal Type: Placement
Latest Entry Price: $0.015
Price Performance Since Entry: +47%
Company: Neuren Pharmaceuticals Ltd (ASX:NEU)
Sector: Biotech
Deal Type: On-market purchase
Latest Entry Price: $1.20 – $1.50
Price Performance Since Entry: +1,224%
Company: Dimerix Ltd (ASX:DXB)
Sector: Biotech
Deal Type: Rights Issue
Raise Amount: $800,000
Latest Entry Price: $0.08 with 1:1 option, strike $0.126
Price Performance Since Entry: $0.505 +469%
Company: Noviqtech Ltd (ASX:NVQ)
Sector: Blockchain
Deal Type: Placement
Raise Amount: $1M
Latest Entry Price: $0.02 with 1:1 option $0.08 strike
Price Performance Since Entry: +40%
Company: Critica Limited (ASX:CRI)
Sector: REE
Deal Type: Placement
Raise Amount: $1M
Latest Entry Price: $0.0075 with a 1:1 CRIO
Price Performance Since Entry: +273%
Company: Patagonia Lithium (ASX:PL3)
Sector: Lithium
Deal Type: IPO
Raise Amount: $8.6M
Latest Entry Price: $0.09 with 1:2 PL3O
Price Performance Since Entry: +44%
Company: Kalgoorlie Gold Mining Limited. (ASX:KAL)
Sector: Gold/Mining
Deal Type: Placement
Raise Amount: $2.3M
Latest Entry Price: $0.026 with 1:2 option $0.032 strike
Price Performance Since Entry: +65%
If you would like more information on future Peak deals, please don’t hesitate to get in touch.
Peak accepts no responsibility for any views expressed and marketing material contained in this email except where the message specifically states otherwise and the sender is authorised to state them to be the views of Peak. Information provided in this email is general advise only and does take account your objectives, financial situation or needs. Before acting on any advice in this email, Peak recommends that you consider whether it is appropriate for your circumstances. If this email contains reference to any financial products, you should obtain the current Product Disclosure Statement (PDS) or other disclosure documents for the particular products and consider this information before making any decisions regarding the products. The Financial Services Guide (FSG) can be found at www.peakassetmanagement.com.au or by telephoning Peak on 1300 304 460

Comments are closed